![](/img/cover-not-exists.png)
Safety and efficacy results of a phase II randomized, placebo-controlled, dose-ranging study of elnd005 (scyllo-inositol) in mild-to-moderate Alzheimer's disease
Salloway, Stephen, Porsteinsson, Anton, Sperling, Reisa, Keren, Ron, van Dyck, Christopher, Tariot, Pierre, Gilman, Sid, Crans, Gerald, Hernandez, Ramon, Quinn, Grainne, Bairu, Menghis, Cedarbaum, JesVolume:
7
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2011.05.1371
Date:
July, 2011
File:
PDF, 105 KB
english, 2011